Welcome to the eXagen DIAGNOSTICS, Inc.™ news room, where you'll find our latest news announcements as well as articles about the increasing importance of prognostic testing in the treatment of cancer and chronic disease.


Events
> None currently scheduled.

Press Releases
> November 1, 2007
Corporate Finance Leader Joins Board of Exagen Diagnostics, Inc. (PDF)

> September 20, 2007
Exagen Diagnostics, Inc. Continues Growth Surge: New Offices in Austin; Corporate Directors Added (PDF)

> May 29, 2007
Exagen Diagnostics, Inc. Announces an Oral Presentation of a Clinical Study on Genomic Biomarkers for Breast Cancer at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting (PDF)

> April 27, 2007
Exagen Diagnostics Adds Marketing Director (PDF)

> Apritl 4, 2007
Exagen Diagnostics, Inc. Leads Next Phase of Genomic Revolution. Company Files for FDA Clearance of Breast Cancer Prognostic Kit (PDF)


Media Coverage
> August 1, 2007 | Pharmacogenomics Reporter
FDA's New Draft IVDMIA Guidance Still Not Clear For Some Industry Stakeholders

> May 30, 2007 | Pharmacogenomics Reporter
Stakeholders Consider If FDA's IVDMIA Draft Guidance Can Inspire Rx/Dx Codevelopment

> May 20, 2007 | Clinical Lab Products
Tight-Fitting Genes (Link)

> May 16, 2007 | Pharmacogenomics Reporter
In a Step Toward 'Demystifying' IVDMIAs, FDA Grants Class II Status to Breast Cancer Prognostics